Publications
5600 Results
- Journal / Conference
- J Clin Oncol 37(suppl; abstr TPS4597); ASCO (5/31-6/4/19, Chicago IL) TIPS, poster session
- Year
- 2019
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/EA8143
PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) vs. observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOGACRIN 8143)
- Journal / Conference
- J Clin Oncol 37(suppl; abstr 8001); American Society of Clinical Oncology (5/31 - 6/4/19, Chicago IL), oral
- Year
- 2019
- Research Committee(s)
- Myeloma
- Study Number(s)
- CTSU/E3A06
E3A06: Randomized Phase III Trial of Lenalidomide versus Observation Alone in Patients with Asymptomatic High-Risk Smoldering Multiple Myeloma
- Journal / Conference
- Clinical Breast Cancer Aug;19(4):225-235; Mar 6 [Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Breast
- PMID
- PMID30928413
- PMC
- PMC6667288
- Study Number(s)
- SWOG-8897
Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study
- Journal / Conference
- American Association for Cancer Research (March 29-Apr 3, 2019 Atlanta, Georgia), poster
- Year
- 2019
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80405
Body mass index, weight loss, and progression and mortality in metastatic colorectal cancer
- Journal / Conference
- Journal of Thoracic Oncology Oct;14(10):1839-1846; May 31. pii: S1556-0864(19)30414-9. doi: 10.1016/j.jtho.2019.05.029. [Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Lung
- PMID
- PMID31158500
- PMC
- PMC7017958
- Study Number(s)
- S1400B
Brief Report: SWOG S1400B (NCT02785913), A Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)
- Journal / Conference
- Journal of Thoracic Oncology Oct;14(10):1847-1852; Jun 10. pii: S1556-0864(19)30462-9. doi: 10.1016/j.jtho.2019.05.041. [Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Lung
- PMID
- PMID31195180
- PMC
- PMC6901020
- Study Number(s)
- S1400D
Brief Report: SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously-treated Patients with Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)
- Journal / Conference
- Society for Clinical Trials (May 19-22, 2019, New Orleans, LA), oral
- Year
- 2019
- Research Committee(s)
- Cancer Care Delivery
Achieving balance between standardization and customization with the Statisticians’ Report Worksheet
- Journal / Conference
- Society for Clinical Trials (May 19-22, 2019, New Orleans, LA), oral
- Year
- 2019
- Research Committee(s)
- Cancer Care Delivery
Improving online tools for clinical trial design
- Journal / Conference
- American Association for Cancer Research (March 29-April 3, 2019, Atlanta, GA), accepted 2/8/19, oral presentation
- Year
- 2019
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- Study Number(s)
- S1609
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) S1609: The Neuroendocrine Cohort
- Journal / Conference
- American Institute for Cancer Research (AICR) Conference (May 15-17, 2019, Chapel Hill, NC), accepted, poster
- Year
- 2019
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80405